Surprisingly, the serum levels of anti-BA.5.2 Nab from HLA-B*15 individuals were significantly lower than that from non-HLA-B*15 (others) cohorts (Figure 4B), confirming that HLA-B*15 individuals had worse humoral responses post BA.5.2 infection. This evidence concerns the gene HLA-B and infection.